Met/Hepatocyte Growth Factor Receptor | Protein Tyrosine Kinase/RTK| CSNpharm

c-Met/HGFR

c-Met/HGFR
第页，共 2 页

货号	产品名	CAS号	信息
CSN17399	Tyrosine Kinase Inhibitor	1021950-26-4	Tyrosine kinase inhibitor is a drug used for advanced renal cell carcinoma.
CSN12733	SU11274	658084-23-2	SU11274 is a selective Met inhibitor with IC50 of 10 nM, no effects on PGDFRβ, EGFR or Tie2.
CSN12934	PHA-665752	477575-56-7	PHA-665752 is a potent, selective and ATP-competitive c-Met inhibitor with IC50 of 9 nM.
CSN23572	Norcantharidin	29745-04-8	Norcantharidin is a potential antitumor agent.
CSN19988	Herbacetin	527-95-7	Herbacetin, a natural product isolated and purified from the herbs of Equisetum hyemale L. It was found to efficiently block the enzymatic activity of SARS-CoV 3CLpro.
CSN24316	Dihexa acetate	2453297-24-8	Dihexa is a blood-brain barrier-permeable angiotensin IV analog which exhibits high affinity to HGF with Kd value of 65pM and induces c-Met phosphorylation in the presence of subthreshold concentrations of HGF and augment HGF-dependent cell scattering.
CSN25585	RON-IN-1	913376-84-8	c-Met/RON Dual Kinase Inhibitor is a potent inhibitor against the kinase activities of HGF receptor c-Met and MSP (Macrophage Stimulating Protein) receptor RON with IC50 of 4 and 9 nM, respectively, and it is reported to inhibit NIH3T3 TRP-Met and U-87 tumor growth in mice in vivo in a dose-dependent manner.
CSN25296	BAY 474	1033767-86-0	BAY 474 is a tyrosine-protein kinase c-Met inhibitor and a structural genomics consortium (SGC) epigenetics probe.